Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining ... Show More
Sep 14
#2553 - Andrew Huberman
Andrew Huberman, PhD, is a neuroscientist, author, and host of the "Huberman Lab" podcast. His latest book, "Protocols: An Operating Manual for the Human Body," will be available on September 22.www.simonandschuster.com/books/Protocols/Andrew-D-Huberman/9781668032145www.youtube.c ... Show More
2h 45m
Sep 2021
MDMA for PTSD with Rick Doblin
Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ... Show More
15m 56s
Nov 2020
The future of psychedelic-assisted psychotherapy | Rick Doblin
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ... Show More
14m 50s
Aug 2019
#65 - Rick Doblin, Ph.D.: MDMA— the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species
<p>In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity's ability to peacefully coexist. Ri ... Show More
3 h